BNTC
Benitec Biopharma Inc.Company with tickers: BNTC
CIK
1808898
CUSIP
08205P209
Shares Outstanding
34,354,334
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $0 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $36,762,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $15,502,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-36,762,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-32,737,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-0.72 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-0.72 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |